News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023
News Conference News AHA 2023 ESPRIT: Intensive BP-Lowering Reduces MACE in Chinese Patients Todd Neale November 13, 2023
News Conference News AHA 2023 Intensive BP Reduction Lowers Dementia Risk in China Rural Hypertension Study Todd Neale November 12, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Daily News Screen for Hypertensive Disorders During Every Prenatal Visit: USPSTF Michael O'Riordan September 25, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts Michael O'Riordan September 08, 2023
News Daily News Study Finds No Increased Risk of CVD Years After Infertility Therapies L.A. McKeown August 11, 2023
News Daily News Even a Single Drink per Day Increases Blood Pressure Michael O'Riordan August 01, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News ESH Upgrades Denervation, Details Comorbidities in New Hypertension Guideline Todd Neale June 27, 2023
News Conference News EuroPCR 2023 Two New Renal Denervation Systems Look Good in Uncontrolled BP Todd Neale May 17, 2023
News Daily News Tight Link Between Ambulatory BP and Mortality Affirmed in Revamped Analysis Todd Neale May 10, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest Caitlin E. Cox April 11, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023